Quick Answer
Greenwich LifeSciences, Inc. reported Research And Development Expense of $12.95 million for the year ending 2024.
- Greenwich LifeSciences, Inc. showed an increase of +68.2% in Research And Development Expense from 2023 to 2024.
- This data is from Greenwich LifeSciences, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2019 to 2024), Greenwich LifeSciences, Inc.'s Research And Development Expense has grown by 396.9%.
- Historical annual values: Fiscal year 2024: $12.95 million | Fiscal year 2023: $7.70 million | Fiscal year 2022: $6.48 million | Fiscal year 2021: $3.56 million | Fiscal year 2020: $1.06 million | Fiscal year 2019: $2.61 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: